Trial Profile
Examination of utility of minodronic acid hydrate to osteoporosis by ovarian insufficiency after gynecologic disease treatment
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Jul 2016
Price :
$35
*
At a glance
- Drugs Minodronic acid (Primary)
- Indications Osteoporosis
- Focus Biomarker; Therapeutic Use
- 05 Jul 2016 Status changed from recruiting to completed.
- 18 Jan 2013 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan
- 16 Jul 2012 New trial record